Login
Related Links
Advertise on this site?
Advertising opportunities on Gene Therapy Net include standard size banners as well as text ads. Click here for more information about advertising.
You can also make a donation by PayPal and support the Gene Therapy Net website.
Companies - C
Cardium Therapeutics Medical technology company primarily focused on the development and commercialization of novel biologic therapeutics and medical devices for cardiovascular and ischemic disease. |
|
CD Bioparticles CD Bioparticles specializes in the development of tools for gene delivery and therapy, offering scientists various customized solutions, including DiagPoly™ PEI PLGA Nanoparticles and DNA & RNA Delivery Particles. The company also provides custom nucleic acid delivery particle synthesis and construction services applicable to gene therapy research. . |
|
Cellectis SA Cellectis proprietary technologies and platform are based upon a naturally occurring class of DNA endonucleases, the Meganucleases and DNA recombination. |
|
Cellerant Therapeutics Inc. Biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. |
|
CellGenix Technologie Transfer GmbH CellGenix develops, manufactures and markets cell and protein therapeutics for cancer and orthopedic patients, as well as high-quality reagents for therapeutic ex vivo cell processing. |
|
Cenix BioScience GmbH Cenix is a contract research provider specialized in RNAi- and miRNA-based Target Discovery, Target Validation and Drug Mode of Action studies combined with high-content phenotypic analyses. |
|
Clontech Biotechnology supply company offering adenoviral-mediated gene transfer products, like Adeno-X Tet-On®, Adeno-X Tet-Off® Expression Systems for inducible adenoviral protein expression, Adeno-X Virus Purification Kit, Adeno-X Rapid Titer Kit, and Adeno-X Marker Viruses. |
|
Cobra Biologics Ltd Contract manufacturing organisation focusing on the production of Protein, Viral and DNA-based therapeutics at cGMP grade. | |
Copernicus Therapeutics Inc. Biopharmaceutical company utilizing its breakthrough DNA nanoparticle technologies to produce safe and effective DNA drugs. Copernicus' lead products is for cystic fibrosis and hemophilia B. |
|
Creative Biolabs With years of experience in one-stop pre-clinical development services, Creative Biolabs has built a team of experts with solid knowledge regarding gene therapy who are fully competent in services including delivery vehicle development, potency tests, safety and toxicology analysis, solutions of specific gene therapy development for diseases, etc. |
|
Creative Diagnostics Creative Diagnostics offers a variety of research tools and materials related to gene therapy, including AAV antibodies, antigens, ELISA kits, and other reagents specifically designed for gene therapy, and is committed to helping researchers develop AAV-based gene therapy products for various diseases. |
|
Cytologics Provider of human immune cells supporting biopharma companies and research organizations in early-stage discovery of therapies, clinical trials, quality control, manufacturing and commercialization. Their products range from HLA-typed PBMCs to specialty blood products to support biomedical research |
|
Information Companies
Overview of biotechnology companies involved in gene therapy and/or cell therapy, as well as contract research organizations (CRO) and medical supply companies.
The provided information about the companies is just a summary of the information giving on their websites and is therefore not always complete, correct and/or exhaustive. Please visit the companies websites for a complete picture of the company.
Your company not listed? Click here to submit.
Like to work for a company? Find here the perfect job in gene therapy.
Gene Therapy News
- Cell and Gene Therapy Bioassay Services Market Innovations Investigated by Future Scope and Latest Trends A... - WhaTech
Fri, 19 Apr 2024 06:00:2 GMT - Boy with rare blood disorder receives new life-changing gene therapy treatment - AOL
Fri, 19 Apr 2024 04:32:1 GMT - New gene therapy eliminates need for bone marrow transplant. Here's how it works. - MSN
Fri, 19 Apr 2024 02:05:0 GMT - Long Island boy with rare blood disorder undergoes gene therapy - PIX11 New York News
Fri, 19 Apr 2024 01:39:1 GMT - New gene therapy eliminates need for bone marrow transplant. Here's how it works. - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Long Island boy undergoes groundbreaking gene therapy - CBS New York - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Gene Therapy Stops Cancer: Will It Tackle Brain Tumors? - Mirage News
Thu, 18 Apr 2024 23:32:0 GMT - Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV
Thu, 18 Apr 2024 22:56:0 GMT - Hospital gives first dose of gene therapy for DMD in WV - WDTV
Thu, 18 Apr 2024 21:47:0 GMT - Gene Therapy Market Size Poised to Surge USD 52.40 Billion by 2033 - BioSpace
Thu, 18 Apr 2024 21:12:5 GMT - Cancer Gene Therapy Industry is Rising Rapidly Up to USD 18.11 Bn by 2033 - BioSpace
Thu, 18 Apr 2024 21:09:1 GMT - Cell and Gene Therapy Clinical Trials Market Experiencing Rapid Growth 15.09% - BioSpace
Thu, 18 Apr 2024 20:53:3 GMT - AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart ... - Diagnostic and Interventional Cardiology
Thu, 18 Apr 2024 20:38:0 GMT - Gene therapy to treat congestive heart failure gains FDA fast track designation - Healio
Thu, 18 Apr 2024 19:39:3 GMT - 8-year-old from Valley Stream becomes first in NY to undergo gene therapy for rare disease - News 12 Long Island
Thu, 18 Apr 2024 19:37:4 GMT